Skip to content

Observational Evaluation of the Peristomal Skin Condition in Ostomates

Observational Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™ Skin Barriers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01526967
Acronym
OSMOSE
Enrollment
2000
Registered
2012-02-06
Start date
2012-01-31
Completion date
2012-12-31
Last updated
2012-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ostomy

Keywords

ostomy, peristomal skin breakdown, ConvaTec Moldable Skin Barriers

Brief summary

The purpose of this study is to estimate the incidence and severity of peristomal skin lesions and evaluate the progression of the peristomal skin condition at 8-15 days following application of the barrier.

Interventions

None listed

Sponsors

ConvaTec Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subjects who are 18 years old and older. * Subjects who agree to participate in the evaluation and who have signed the informed consent form. * Subjects presenting with a stoma (ileostomy, colostomy or urostomy). * Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier per package insert is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin. OR * Subjects presenting with peristomal skin lesions using a traditional barrier and for whom a decision to replace the traditional barrier with ConvaTec Moldable Technology™ Skin Barrier per package insert is made in the context of routine clinical care.

Exclusion criteria

* Subjects who, according to the investigator, have cognitive problems that prevent them from answering a questionnaire or for whom the evaluation could be a problem. * Subjects who are in a simultaneous clinical evaluation.

Design outcomes

Primary

MeasureTime frameDescription
Peristomal skin conditionAt day 12Change in peristomal skin condition from baseline as assessed with the SACS Instrument

Secondary

MeasureTime frameDescription
Peristomal skin conditionat 1 monthChange in peristomal skin condition from baseline as assessed with the SACS instrument
Level of satisfactionAt 2 monthsSubjects satisfaction as measured with a satisfaction survey
Accessory usageUp to 2 monthsSubjects use of additional products in stoma care.
Peristomal Skin ConditionAt 2 monthsChange in peristomal skin condition from baseline as assessed with the SACS instrument

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026